urtoxazumab
visilizumab
furazolidone
sifalimumab
vedolizumab
tefibazumab
suvratoxumab
polyvalent
liposidomycin
efungumab
coproantibody
etesevimab
bacterioagglutinin
-bac-
immunobiotic
colibacillus
bacterize
brazikumab
matuzumab
colibacillosis
lintuzumab
certolizumab
Gartner's bacillus
pexiganan
cantuzumab
giardia
ixekizumab
Salmonella enteritidis
lasalocid
microbiome
ocrelizumab
coliphage
clofoctol
abrilumab
intetumumab
lacticin
glembatumumab
heterophile antibody
-les-
Forssman antibody
heterophil antibody
bacterioscopical
nebacumab
beta-lactamase
New Delhi metallo-beta-lactamase-1
enterophage
fontolizumab
sonepcizumab
bacteraemia
elotuzumab
stomach flu
evolocumab
tucotuzumab
caplacizumab
dacetuzumab
actoxumab
dysentery
synechococcal
inotuzumab ozogamicin
diastomyelia
balsalazide
bacteriotherapeutic
ruplizumab
ozogamicin
coccic
cefsumide
IgG
bivatuzumab
vaccinate
onartuzumab
immunoglobulin G
labetuzumab
colibacilluria
rovelizumab
tomopenem
oximonam
pirazmonam
ozoralizumab
sibrotuzumab
amlitelimab
craps
gastro
bacmecillinam
flucloxacillin
inflammatory bowel disease
sulopenem
sanfetrinem
brobactam
tisotumab
meropenem
-zumab
vobarilizumab
immune
bacterio-
cestodiasis
bactericidin
MacConkey agar
lactococcin
verbal diarrhea